Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Zabini, D; Crnkovic, S; Xu, H; Tscherner, M; Ghanim, B; Klepetko, W; Olschewski, A; Kwapiszewska, G; Marsh, LM.
High-mobility group box-1 induces vascular remodelling processes via c-Jun activation.
J Cell Mol Med. 2015; 19(5):1151-1161
Doi: 10.1111/jcmm.12519
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Marsh Leigh
- Zabini-Polzer Diana
- Co-authors Med Uni Graz
- Crnkovic Slaven
- Kwapiszewska-Marsh Grazyna
- Olschewski Andrea
- Tscherner Maria
- XU Hui
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Extracellular high-mobility group box-1 (HMGB1) acts as a signalling molecule during inflammation, cell differentiation and angiogenesis. Increased abundance of HMGB1 is associated with several pathological disorders such as cancer, asthma and chronic obstructive pulmonary disease (COPD). In this study, we investigated the relevance of HMGB1 in the pathological remodelling present in patients with idiopathic pulmonary arterial hypertension (IPAH) and pulmonary hypertension (PH) associated with COPD. Remodelled vessels present in COPD with PH and IPAH lung samples were often surrounded by HMGB1-positive cells. Increased HMGB1 serum levels were detected in both patient populations compared to control samples. The effects of physiological HMGB1 concentrations were then examined on cellular responses in vitro. HMGB1 enhanced proliferation of pulmonary arterial smooth muscle cells (PASMC) and primary human arterial endothelial cells (PAEC). HMGB1 stimulated p38, extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) phosphorylation. Furthermore, activation of the downstream AP-1 complex proteins c-Fos and c-Jun was observed. Silencing of c-Jun ablated the HMGB1-induced proliferation in PASMC. Thus, an inflammatory component such as HMGB1 can contribute to PASMC and PAEC proliferation and therefore potentially to vascular remodelling and PH pathogenesis. © 2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Blotting, Western -
- Cell Proliferation - drug effects
- Cell Proliferation - genetics
- Cells, Cultured -
- Endothelial Cells - drug effects
- Endothelial Cells - metabolism
- Enzyme Activation - drug effects
- Familial Primary Pulmonary Hypertension - genetics
- Familial Primary Pulmonary Hypertension - metabolism
- Familial Primary Pulmonary Hypertension - pathology
- Female -
- HMGB1 Protein - blood
- HMGB1 Protein - metabolism
- HMGB1 Protein - pharmacology
- Humans -
- Hypertension, Pulmonary - genetics
- Hypertension, Pulmonary - metabolism
- Hypertension, Pulmonary - pathology
- Immunohistochemistry -
- JNK Mitogen-Activated Protein Kinases - genetics
- JNK Mitogen-Activated Protein Kinases - metabolism
- Male -
- Middle Aged -
- Muscle, Smooth, Vascular - cytology
- Myocytes, Smooth Muscle - drug effects
- Myocytes, Smooth Muscle - metabolism
- Pulmonary Artery - cytology
- RNA Interference -
- Receptor for Advanced Glycation End Products - genetics
- Receptor for Advanced Glycation End Products - metabolism
- Reverse Transcriptase Polymerase Chain Reaction -
- Signal Transduction - drug effects
- Signal Transduction - genetics
- Toll-Like Receptor 4 - genetics
- Toll-Like Receptor 4 - metabolism
- Vascular Remodeling - drug effects
- Vascular Remodeling - genetics
- Vascular Remodeling - physiology
- Find related publications in this database (Keywords)
- alarmins
- HMGB1
- inflammation
- proliferation
- pulmonary hypertension